abrdn Europe ex UK Income Equity Fund Standard Life AccumulationRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 9.0 | 17.2 | -0.6 | 13.3 | 5.7 | |
+/-Cat | -0.4 | 1.7 | 8.2 | -0.3 | -0.5 | |
+/-B’mrk | 1.1 | -0.1 | 6.9 | -1.7 | -1.3 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 26/04/2024 | GBP 2.39 | |
Day Change | 0.50% | |
Morningstar Category™ | Europe ex-UK Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | GB00B87XTB15 | |
Fund Size (Mil) 26/04/2024 | GBP 360.60 | |
Share Class Size (Mil) 26/04/2024 | GBP 17.45 | |
Max Initial Charge | - | |
Ongoing Charge 15/02/2024 | 0.10% |
Investment Objective: abrdn Europe ex UK Income Equity Fund Standard Life Accumulation |
To generate income and some growth over the long term (5 years or more) by investing in European equities (company shares). The fund will invest at least 70% in equities and equity related securities of companies listed, incorporated, or domiciled in European countries, or companies that derive a significant proportion of their revenues or profits from European operations or have a significant proportion of their assets there. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Stuart Brown 01/01/2021 | ||
Inception Date 05/04/2009 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE World Eur Ex UK TR GBP | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for abrdn Europe ex UK Income Equity Fund Standard Life Accumulation | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 5.74 |
SAP SE | Technology | 4.41 |
ASML Holding NV | Technology | 4.30 |
TotalEnergies SE | Energy | 4.05 |
Novartis AG Registered Shares | Healthcare | 3.97 |
Increase Decrease New since last portfolio | ||
abrdn Europe ex UK Income Equity Fund Standard Life Accumulation |